The European Association for Clinical Pharmacology and Therapeutics—25 years’ young and going strong Jamie J. ColemanCaroline SamerYlva Böttiger Special Article Open access 16 May 2019 Pages: 743 - 750
Impact of drugs on venous thromboembolism risk in surgical patients Alenka Premuš Marušič KovačičMartin CaprndaDanijel Petrovič Review 05 February 2019 Pages: 751 - 767
The evidence-based choice for antipsychotics in children and adolescents should be guaranteed Daria PutignanoAntonio ClavennaMaurizio Bonati Review 07 February 2019 Pages: 769 - 776
Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients C. PfrepperS. DetersS. Petros Clinical Trial 18 February 2019 Pages: 777 - 784
Relationship between warfarin dosage and international normalized ratio: a dose–response analysis and evaluation based on multicenter data Ling XueYuzhen ZhangLiyan Miao Pharmacodynamics 29 April 2019 Pages: 785 - 794
IL-2 gene polymorphisms affect tacrolimus response in myasthenia gravis Yang ShumeiLi YiYang Huan Pharmacogenetics 07 February 2019 Pages: 795 - 800
Sex-by-formulation interaction in bioequivalence trials with transdermal patches Esperanza González-RojanoJulio MarcoteguiAlfredo García-Arieta Pharmacokinetics and Disposition 06 February 2019 Pages: 801 - 808
Dried blood spot testing for estimation of renal function and analysis of metformin and sitagliptin concentrations in diabetic patients: a cross-sectional study Maike Scherf-ClavelEdwin AlbertPetra Högger Pharmacokinetics and Disposition 31 January 2019 Pages: 809 - 816
Downregulation of ABCB1 gene in patients with total hip or knee arthroplasty influences pharmacokinetics of rivaroxaban: a population pharmacokinetic-pharmacodynamic study Jurij ZdovcMaja PetreIztok Grabnar Pharmacokinetics and Disposition 06 February 2019 Pages: 817 - 824
Feasibility of and patients’ perspective on nilotinib dried blood spot self-sampling Christel C. L. M. BoonsLonneke TimmersN. Harry Hendrikse Pharmacokinetics and Disposition Open access 07 February 2019 Pages: 825 - 829
Monitoring of tobramycin serum concentrations in selected critically ill patients receiving selective decontamination of the digestive tract: a retrospective evaluation J. E. MöhlmannM. van LuinM. R. de Maat Pharmacokinetics and Disposition 18 February 2019 Pages: 831 - 836
Is there a potential association between spironolactone and the risk of new-onset diabetes in a cohort of older patients with heart failure? Sandra KorolMichel WhiteSylvie Perreault Pharmacoepidemiology and Prescription 13 February 2019 Pages: 837 - 847
Fall-risk-increasing adverse reactions—is there value in easily accessible drug information? A case-control study Susanne SchiekKatja HildebrandtThilo Bertsche Pharmacoepidemiology and Prescription 13 February 2019 Pages: 849 - 857
Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment Toshinori HiraiKazuhiko HanadaToshimasa Itoh Pharmacoepidemiology and Prescription 15 February 2019 Pages: 859 - 866
Correction to: Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment Toshinori HiraiKazuhiko HanadaToshimasa Itoh Correction 19 March 2019 Pages: 867 - 867
Severe reduction in tacrolimus concentrations with concomitant metamizole (dipyrone) therapy in transplant patients Ali SigaroudiAlexander JetterStefan Weiler Letter to the Editor 29 January 2019 Pages: 869 - 872
Is an elevated burden of antiarrhythmic drug (AAD) side-effects the unavoidable price to be traded for a durable suppression of AF relapses in ablated patients? The weaknesses and risks of the AAD suppression algorithm used by current models of AF secondary prevention after catheter ablation Renato De Vecchis Letter to the Editor 29 January 2019 Pages: 873 - 874
Dabigatran levels in omeprazole versus pantoprazole-treated patients with atrial fibrillation: is there a difference? Tomáš BolekMatej SamošMarián Mokán Letter to the Editor 12 February 2019 Pages: 875 - 877